The patent case involving Novartis' drug "Glivec" in India was related to:
In Novartis AG v. Union of India (2013) the Supreme Court refused a patent for the beta-crystalline form of imatinib mesylate (Glivec) under Section 3(d) of the Patents Act,…
Choose your answer
The patent case involving Novartis' drug "Glivec" in India was related to:
Answer and explanation
Correct answer B
In Novartis AG v. Union of India (2013) the Supreme Court refused a patent for the beta-crystalline form of imatinib mesylate (Glivec) under Section 3(d) of the Patents Act, 1970, holding that a new form of a known substance without enhanced therapeutic efficacy is not patentable, so the case related to "Evergreening".
Practice for these exams
-
All India Bar Examination (AIBE)
Subject revision
See pack details on LawMint.net -
UGC NET Law
Subject revision
See pack details on LawMint.net -
IIT Kharagpur LL.M. Entrance
Subject revision
See pack details on LawMint.net -
CUET PG Law (LL.M.)
Subject revision
-
Patent Agent
Subject revision